JLPC(SH:600513) Zheng Quan Shi Bao Wang·2025-07-17 12:10Group 1 - The stock of Lianhuan Pharmaceutical (600513) increased by 2.02% with a turnover rate of 27.60% and a trading volume of 1.35 billion yuan, showing a fluctuation of 9.79% [2] - The stock was listed on the Shanghai Stock Exchange due to its high turnover rate, with a net selling amount of 25.91 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 235 million yuan, with a buying amount of 105 million yuan and a selling amount of 131 million yuan, resulting in a net selling of 25.91 million yuan [2] Group 2 - The main buying brokerage was Guotai Junan Securities Headquarters, with a buying amount of 42.78 million yuan, while the largest selling brokerage was Guotai Junan Securities Shanghai Songjiang District Zhongshan Road Securities Office, with a selling amount of 51.84 million yuan [2][3] - The stock experienced a net outflow of 91.91 million yuan in main funds, with a significant outflow of 15.72 million yuan from large orders and 76.19 million yuan from major funds, while the net inflow over the past five days was 48.01 million yuan [2] - The company reported a first-quarter revenue of 628 million yuan, representing a year-on-year increase of 18.78%, but the net profit was 23.06 million yuan, a year-on-year decrease of 29.15% [2] Group 3 - On July 15, the company released a half-year performance forecast, expecting a net loss between 45 million yuan and 38 million yuan [3] - The trading data on July 17 showed continued activity with significant buying and selling amounts from various brokerages, indicating ongoing market interest [3][4]